世界の進行性再発性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Progressive Relapsing Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4818
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、進行性再発性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・進行性再発性多発性硬化症治療の市場動向
・企業の競争状況、市場シェア
・進行性再発性多発性硬化症治療の種類別市場規模（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）
・進行性再発性多発性硬化症治療の用途別市場規模（診療所、病院、その他）
・進行性再発性多発性硬化症治療の北米市場規模2016-2027（アメリカ、カナダ）
・進行性再発性多発性硬化症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・進行性再発性多発性硬化症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・進行性再発性多発性硬化症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・進行性再発性多発性硬化症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Cognosci Inc、Genzyme Corp、MedImmune LLC、VivaCell Biotechnology Espana SL）
・結論

Market Analysis and Insights: Global Progressive Relapsing Multiple Sclerosis Treatment Market
The global Progressive Relapsing Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Progressive Relapsing Multiple Sclerosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Progressive Relapsing Multiple Sclerosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Progressive Relapsing Multiple Sclerosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Progressive Relapsing Multiple Sclerosis Treatment market.

Global Progressive Relapsing Multiple Sclerosis Treatment Scope and Market Size
Progressive Relapsing Multiple Sclerosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Progressive Relapsing Multiple Sclerosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
COG-133
GZ-402668
Inebilizumab
VCE-0032
Others

Segment by Application
Clinic
Hopital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Cognosci Inc
Genzyme Corp
MedImmune LLC

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 COG-133
1.2.3 GZ-402668
1.2.4 Inebilizumab
1.2.5 VCE-0032
1.2.6 Others
1.3 Market by Application
1.3.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hopital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Perspective (2016-2027)
2.2 Progressive Relapsing Multiple Sclerosis Treatment Growth Trends by Regions
2.2.1 Progressive Relapsing Multiple Sclerosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Progressive Relapsing Multiple Sclerosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Progressive Relapsing Multiple Sclerosis Treatment Industry Dynamic
2.3.1 Progressive Relapsing Multiple Sclerosis Treatment Market Trends
2.3.2 Progressive Relapsing Multiple Sclerosis Treatment Market Drivers
2.3.3 Progressive Relapsing Multiple Sclerosis Treatment Market Challenges
2.3.4 Progressive Relapsing Multiple Sclerosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Revenue
3.1.1 Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Progressive Relapsing Multiple Sclerosis Treatment Revenue
3.4 Global Progressive Relapsing Multiple Sclerosis Treatment Market Concentration Ratio
3.4.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Progressive Relapsing Multiple Sclerosis Treatment Revenue in 2020
3.5 Progressive Relapsing Multiple Sclerosis Treatment Key Players Head office and Area Served
3.6 Key Players Progressive Relapsing Multiple Sclerosis Treatment Product Solution and Service
3.7 Date of Enter into Progressive Relapsing Multiple Sclerosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Progressive Relapsing Multiple Sclerosis Treatment Breakdown Data by Type
4.1 Global Progressive Relapsing Multiple Sclerosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Type (2022-2027)

5 Progressive Relapsing Multiple Sclerosis Treatment Breakdown Data by Application
5.1 Global Progressive Relapsing Multiple Sclerosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size (2016-2027)
6.2 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type
6.2.1 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2027)
6.3 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application
6.3.1 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2027)
6.4 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country
6.4.1 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size (2016-2027)
7.2 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type
7.2.1 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2027)
7.3 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application
7.3.1 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2027)
7.4 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country
7.4.1 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type
8.2.1 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application
8.3.1 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Region
8.4.1 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size (2016-2027)
9.2 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type
9.2.1 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application
9.3.1 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country
9.4.1 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type
10.2.1 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application
10.3.1 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country
10.4.1 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Cognosci Inc
11.1.1 Cognosci Inc Company Details
11.1.2 Cognosci Inc Business Overview
11.1.3 Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Introduction
11.1.4 Cognosci Inc Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021)
11.1.5 Cognosci Inc Recent Development
11.2 Genzyme Corp
11.2.1 Genzyme Corp Company Details
11.2.2 Genzyme Corp Business Overview
11.2.3 Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Introduction
11.2.4 Genzyme Corp Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021)
11.2.5 Genzyme Corp Recent Development
11.3 MedImmune LLC
11.3.1 MedImmune LLC Company Details
11.3.2 MedImmune LLC Business Overview
11.3.3 MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Introduction
11.3.4 MedImmune LLC Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021)
11.3.5 MedImmune LLC Recent Development
11.4 VivaCell Biotechnology Espana SL
11.4.1 VivaCell Biotechnology Espana SL Company Details
11.4.2 VivaCell Biotechnology Espana SL Business Overview
11.4.3 VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Introduction
11.4.4 VivaCell Biotechnology Espana SL Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021)
11.4.5 VivaCell Biotechnology Espana SL Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of COG-133
Table 3. Key Players of GZ-402668
Table 4. Key Players of Inebilizumab
Table 5. Key Players of VCE-0032
Table 6. Key Players of Others
Table 7. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Regions (2016-2021)
Table 11. Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Regions (2022-2027)
Table 13. Progressive Relapsing Multiple Sclerosis Treatment Market Trends
Table 14. Progressive Relapsing Multiple Sclerosis Treatment Market Drivers
Table 15. Progressive Relapsing Multiple Sclerosis Treatment Market Challenges
Table 16. Progressive Relapsing Multiple Sclerosis Treatment Market Restraints
Table 17. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Players (2016-2021)
Table 19. Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Relapsing Multiple Sclerosis Treatment as of 2020)
Table 20. Ranking of Global Top Progressive Relapsing Multiple Sclerosis Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Progressive Relapsing Multiple Sclerosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Progressive Relapsing Multiple Sclerosis Treatment Product Solution and Service
Table 24. Date of Enter into Progressive Relapsing Multiple Sclerosis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Cognosci Inc Company Details
Table 65. Cognosci Inc Business Overview
Table 66. Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Product
Table 67. Cognosci Inc Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 68. Cognosci Inc Recent Development
Table 69. Genzyme Corp Company Details
Table 70. Genzyme Corp Business Overview
Table 71. Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Product
Table 72. Genzyme Corp Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 73. Genzyme Corp Recent Development
Table 74. MedImmune LLC Company Details
Table 75. MedImmune LLC Business Overview
Table 76. MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Product
Table 77. MedImmune LLC Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 78. MedImmune LLC Recent Development
Table 79. VivaCell Biotechnology Espana SL Company Details
Table 80. VivaCell Biotechnology Espana SL Business Overview
Table 81. VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Product
Table 82. VivaCell Biotechnology Espana SL Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 83. VivaCell Biotechnology Espana SL Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. COG-133 Features
Figure 3. GZ-402668 Features
Figure 4. Inebilizumab Features
Figure 5. VCE-0032 Features
Figure 6. Others Features
Figure 7. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hopital Case Studies
Figure 10. Others Case Studies
Figure 11. Progressive Relapsing Multiple Sclerosis Treatment Report Years Considered
Figure 12. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Regions (2022-2027)
Figure 16. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Players in 2020
Figure 17. Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Relapsing Multiple Sclerosis Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Progressive Relapsing Multiple Sclerosis Treatment Revenue in 2020
Figure 19. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 23. North America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 24. North America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Country (2016-2027)
Figure 25. United States Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 29. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 30. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Share by Country (2016-2027)
Figure 31. Germany Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Share by Region (2016-2027)
Figure 41. China Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Cognosci Inc Revenue Growth Rate in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021)
Figure 61. Genzyme Corp Revenue Growth Rate in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021)
Figure 62. MedImmune LLC Revenue Growth Rate in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021)
Figure 63. VivaCell Biotechnology Espana SL Revenue Growth Rate in Progressive Relapsing Multiple Sclerosis Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Primary Progressive Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4790 2021年4月 94Pages
QYResearch社発行の本調査資料では、一次進行性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、ラキニモドナトリウム、その他）、用途別市場規模（病院、診療所、...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2021-2027
QYR2104Z5441 2021年4月 90Pages
QYResearch社発行の本調査資料では、多発性硬化症幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、脳室内）、用途別市場規模（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3956 2021年4月 93Pages
QYResearch社発行の本調査資料では、多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫調節剤、免疫抑制剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Sclerosis Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3955 2021年4月 90Pages
QYResearch社発行の本調査資料では、多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ベータインターフェロン、コルチコステロイド、モノクローナル抗体、抗腫瘍剤、その他）、用途別市場規模（病院薬局、小売薬局、eコマース）、主...

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

世界の進行性運動失調及び脱力障害症候群治療市場規模・現状・予測（2021年-2027年）

Global Treatment for Syndromes of Progressive Ataxia and Weakness Disorders Market Size, Status and Forecast 2021-2027
QYR2104Z5740 2021年4月 98Pages
QYResearch社発行の本調査資料では、進行性運動失調及び脱力障害症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、小分子技術）、用途別市場規模（フリードライヒ運動失調症、遺伝性ニューロパチー、マチャドジョセフ病...

世界の進行性多巣性白質脳症治療市場規模・現状・予測（2021年-2027年）

Global Progressive Multifocal Leukoencephalopathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4817 2021年4月 94Pages
QYResearch社発行の本調査資料では、進行性多巣性白質脳症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗レトロウイルス療法、抗ウイルス/抗JCV、その他）、用途別市場規模（病院薬局、ドラッグストア、小売薬局）、主要地域別市場規模（...

世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場規模・現状・予測（2021年-2027年）

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0301 2021年4月 90Pages
QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ルーゲーリック病）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、幹細胞治療）、用途別市場規模（病院、診断センター、クリニック、小売薬局）、主要地域別市場規模（北米、...

世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場規模・現状・予測（2021年-2027年）

世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…
世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…
世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…